INHIBITION OF 5-FLUOROURACIL-INDUCED OCULAR IRRITATION BY OCULAR ICE PACKS

被引:0
|
作者
LOPRINZI, CL
WENDER, DB
VEEDER, MH
OFALLON, JR
VAUGHT, NL
DOSE, AM
GHOSH, C
BARTEL, J
LEITCH, JM
机构
[1] SIOUXLAND HEMATOL ONCOL ASSOCIATES,SIOUX CITY,IA
[2] ILLINOIS ONCOL RES ASSOC,COMMUNITY CLIN ONCOL PROGRAM,PEORIA,IL
[3] MAYO CLIN & MAYO FDN,CANC STAT UNIT,ROCHESTER,MN 55905
[4] CEDAR RAPIDS ONCOL PROJECT,CEDAR RAPIDS,IA
[5] SASKATCHEWAN CANC FDN,ALLAN BLAIR MEM CLIN,REGINA,SK,CANADA
[6] ST LUKES HOSP,CCOP,FARGO,ND
关键词
5-FLUOROURACIL-INDUCED OCULAR TOXICITY; 5-FLUOROURACIL-INDUCED CONJUNCTIVITIS; OCULAR ICE PACKS;
D O I
10.1002/1097-0142(19940801)74:3<945::AID-CNCR2820740324>3.0.CO;2-C
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. This clinical trial was developed to determine whether ocular ice pack therapy would decrease 5-fluorouracil (5-FU)-induced ocular toxicity. Methods. Sixty-two patients who suffered from 5-FU-induced ocular toxicity, and were scheduled to receive another cycle of the chemotherapy that caused the ocular toxicity, were entered in this clinical trial. A randomized, crossover design was used, with patients documenting their ocular toxicity by the use of daily diaries. Results. The results from the first cycle of treatment suggested that ocular ice pack therapy decreased 5-FU-induced ocular toxicity (P = 0.056). The 38 evaluable patients in the crossover analyses demonstrated decreased ocular toxicity with ocular ice pack therapy (p=.001). The ocular ice pack therapy was well tolerated by most of the study participants. Conclusion. Ocular ice pack therapy appears to lessen 5-FU-induced ocular toxicity to a clinically moderate degree. Better methods for decreasing 5-FU-induced ocular toxicity are necessary.
引用
收藏
页码:945 / 948
页数:4
相关论文
共 50 条
  • [1] 5-Fluorouracil-induced leukoencephalopathy
    Manikandan, Muthu
    Azariah, Biju
    Sharma, Rajiv
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (07) : 2076 - 2078
  • [2] 5-FLUOROURACIL-INDUCED PSEUDOPORPHYRIA
    LAIDMAN, PJ
    GEBAUER, K
    TROTTER, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (04): : 385 - 385
  • [3] 5-Fluorouracil-induced encephalopathy
    Yano, Yudai
    Kuriyama, Akira
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (09) : 532 - 533
  • [4] Enhancement of 5-Fluorouracil-induced In Vitro and In Vivo Radiosensitization with MEK Inhibition
    Urick, Mary Ellen
    Chung, Eun Joo
    Shield, William P., III
    Gerber, Naamit
    White, Ayla
    Sowers, Anastasia
    Thetford, Angela
    Camphausen, Kevin
    Mitchell, James
    Citrin, Deborah E.
    CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5038 - 5047
  • [5] 5-fluorouracil-induced reticulated hyperpigmentation
    Sanz-Sanchez, T.
    Cordoba, S.
    Jimenez-Ayala, B.
    Borbujo, J. M.
    ACTAS DERMO-SIFILIOGRAFICAS, 2008, 99 (07): : 573 - 574
  • [6] 5-FLUOROURACIL-INDUCED CORONARY VASOSPASM
    BURGER, AJ
    MANNINO, S
    AMERICAN HEART JOURNAL, 1987, 114 (02) : 433 - 436
  • [7] 5-Fluorouracil-Induced Coronary Vasospasm
    Arya, Sumedha
    Ahmad, Tehmina
    Chin-Yee, Benjamin
    Mak, Susanna
    CJC OPEN, 2019, 1 (01) : 39 - 40
  • [8] 5-Fluorouracil-induced coronary vasospasm
    Bathina, Jaya D.
    Yusuf, Syed Wamique
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2010, 11 (04) : 281 - 284
  • [9] 5-FLUOROURACIL AND OCULAR TOXICITY
    FORBES, JE
    BRAZIER, DJ
    SPITTLE, M
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (07) : 465 - 466
  • [10] 5-Fluorouracil-induced erythema multiforme
    Lo, SK
    Yip, D
    Leslie, M
    Harper, P
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (03) : 219 - 221